Concerns growing over low-priced drug incentive system

Published: 2009-11-19 06:58:00

Updated: 2009-11-19 06:58:00

There are mounting concerns in the local pharmaceutical industry over the spreading rumor that the government is said to push up with a plan to offer an incentive to a medical institution which purchases a drug at a cheaper price than the standard price.

Aimed at providing cheaper drugs for pa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK